Skip to main content
. 2020 Jul 22;16(1):162–176. doi: 10.2215/CJN.02840320

Figure 5.

Figure 5.

Klotho-centric therapies in kidney disease, including increase in endogenous production or administration of exogenous Klotho protein or cDNA. miRNA, microRNA; PPAR-r, peroxisome proliferator-activated receptor gamma.